Based on our findings, we hypothesized that NBP derivatives, which showed better blood-brain barrier crossing capability and retained the enhancing effects on SIRT3, might be considered as promising drug candidates for ischemic stroke. The gene discussed is SIRT3; the disease is ischemic stroke.